GlassScriptPhysician profile
Joseph B Hollis
NPI 1477504603
$1,316.67
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $339 · 2021: $507.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $217.82 | 2019-2021 | |
| Novo Nordisk INC | $166.29 | 2019-2021 | |
| Glaxosmithkline, LLC. | $151.56 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $137.77 | 2019-2021 | |
| Abbvie INC. | $72.90 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.30 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $52.13 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $38.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.58 | 2021 | |
| Alfasigma USA, INC. | $28.36 | 2020 | |
| Radius Health, INC. | $27.44 | 2020 | |
| Lilly USA, LLC | $25.64 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $25.01 | 2019 | |
| Neurocrine Biosciences, INC. | $23.25 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $22.63 | 2020 | |
| Redhill Biopharma INC. | $20.80 | 2021 | |
| Janssen Biotech, INC. | $19.48 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.23 | 2021 | |
| Esperion Therapeutics, INC. | $16.92 | 2021 | |
| Ironwood Pharmaceuticals, INC | $16.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.73 | 2019 | |
| Amgen INC. | $15.12 | 2019 | |
| Astellas Pharma US INC | $14.15 | 2019 | |
| Pfizer INC. | $13.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hollis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.